Explore our library of blogs, insights, research papers, and more information on compliance in the life sciences industry.
For compliance professionals working in life sciences companies, a comprehensive understanding of the diverse payment categories, financial transactions, and transfers of values required by the Center for Medicare and Medicaid Services (CMS) for reporting is crucial. By thoroughly understanding the scope of financial transactions made by reporting entities to covered recipients, compliance professionals can empower […]
As we step into 2024, life sciences companies continue to introduce innovative treatments to the market that improve patient health while adhering to the rules and regulations enacted by the regulatory authorities and identifying and mitigating compliance risks. While data-driven compliance platforms are enabling compliance professionals to ensure compliance with the evolving rules and regulations, […]
The Physician Payments Sunshine Act requires life sciences companies to report any payments or other transfers of value made to physicians and teaching hospitals to the Centers for Medicare & Medicaid Services (CMS) “Physicians” include those legally authorized to practice medicine, osteopathy, dentistry, dental surgery, podiatry, optometry, and chiropractic medicine. Over the years, life sciences companies […]
Risk mitigation enables organizations to identify and address critical risks before the regulatory authorities do. The complex compliance requirements enacted by entities such as the U.S. Department of Justice (DOJ) and the Office of Inspector General (OIG) place immense pressure on life sciences companies and compliance professionals. With the consequences of non-compliance being fines, legal […]
Before delving into the mechanics of Sunshine Act reporting, it is useful to reflect on the history and rationale behind this significant piece of legislation. The Physician Payments Sunshine Act, now known simply as the Sunshine Act, was signed into law by President Barack Obama on March 23, 2010, as part of the Patient Protection […]
In the pharmaceutical industry, maintaining compliance with the laws and regulations is paramount. The Anti-kickback (AKS) Law prohibits the exchange of any form of remuneration to induce or reward referrals of federal healthcare program business. Violations can lead to severe penalties, including fines, imprisonment, and exclusion from federal healthcare programs. As such, pharmaceutical compliance professionals […]
Your usage of this site constitutes acceptance of our Terms of Use & Data Policy. The material on this say may not be reproduced, distributed, transmitted, cached, or otherwise used without qordata’s consent. qordata is an Equal Opportunity Employer. All qualified individuals are accepted as employees and will receive consideration for employment without regard to race, gender, color, age, religion, sex, national origin, protected veteran status, or any other characteristic protected under federal, state, or local law.
© qordata 2024. All rights reserved | Sitemap | Privacy Policy | Terms of Use